PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Can we treat a 'new' coronary heart disease risk factor?

Treating depression in those with coronary heart disease: CODIACS Vanguard Randomized Controlled Trial

2013-03-21
(Press-News.org) NEW YORK – Depressive symptoms after heart disease are associated with a markedly increased risk of death or another heart attack. However, less has been known about whether treating heart attack survivors for depressive symptoms could relieve these symptoms, be cost-effective, and ultimately, reduce medical risk? Columbia University Medical Center's Karina W. Davidson, PhD and her research team now report a patient-centered approach that answers these questions in the affirmative.

With a grant from the National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI), Dr. Karina Davidson, director of the Center for Behavioral Cardiovascular Health at CUMC, and her team completed a randomized controlled trial with 150 patients with elevated depressive symptoms two to six months after hospitalization for heart disease. Patients were recruited from seven centers across the United States (NewYork-Presbyterian Hospital/Columbia University Medical Center; Washington University; University of Pennsylvania; Emory University – two sites; and Yale University – two sites); 73 received six months of patient-preference depression care, and 77 received six months of depression care determined by their physician upon notification that the patient had elevated depressive symptoms.

Dr. Davidson will give a presentation about these findings today at the Society of Behavioral Medicine 2013 Annual Meeting & Scientific Sessions (San Francisco, March 20-23). The study was published online on March 7, 2013, in JAMA Internal Medicine.

In the study, those in the patient-preference group were given a choice of therapy or antidepressants, or both. "We tried to help them really think through, what does it take to take a pill every day, what it takes to talk to a person about painful feelings and do homework. We then considered what would fit into their life," said Dr. Davidson. "Every six to eight weeks, we revisited how their chosen treatment was working for them and helped them make adjustments based upon their feedback."

Therapy in this study was given virtually (by phone or web-based) by two counselors (one at CUMC and one at Yale), to ensure that patients had access to clinicians of a similar skill set. The virtual therapy also helped connect patients with therapists at times that were most convenient for them. "Maybe 8:00 pm at your home is the right time for you, but not 8:00 pm if you have to go to a clinic or hospital, wait half an hour, and then travel back home afterwards," said Dr. Davidson, who is also professor of behavioral medicine in medicine, cardiology, and psychiatry, CUMC.

The therapy used in the trial was problem-solving treatment (PST)—a practical, hands-on approach that asks patients to choose the problems in their life that they want to tackle and teaches them how to problem-solve. Patients were assigned homework to try the solutions and then returned to talk about what worked and what didn't, and tackle the next problem.

"What we want to know is whether this kind of patient-preference, centralized, heart disease-specific depression care was feasible and effective, and whether it also has the tantalizing possibility of being cost-neutral within six months," said Dr. Davidson.

The findings showed that depressive symptoms were reduced more in the patient-preference, centralized depression care group than in the group of patients receiving usual care. At the start of the trial, patients had an average of 19 points on the Beck Depression Inventory (BDI) depression scale. At the end of the trial, BDI scores in the patient-preference group were significantly reduced, by an average of 3𔃄 points more than in the other group. Getting below 10 on the BDI puts one in the normal range—and almost half of the group who received patient-preference, centralized treatment got down to the normal range, compared with only one-third of the usual-care group.

Researchers found that running centralized depression care at seven sites nationwide was effective, suggesting that it is feasible to deliver depression care to those who do not have specialists in their area. Overall, the total health care costs for the patient-preference depression treatment group was $325 less than for the usual-care group, even when factoring in the cost of therapy. And fewer hospitalizations were seen in the patient-preference group than in the usual-care group.

"We really wanted to know whether we can treat depressive symptoms in a large group of patients nationwide and if doing so ultimately lowers their risk of death or having another heart attack," said Dr. Davidson. "Routine management of depressive symptoms in heart disease patients has been poor and lacked an evidence base. With these results, which will help us understand what we can do to relieve the suffering of those who experience both disabling problems, we can now propose a large, national trial more effectively and efficiently."

###

The paper is titled, "Centralized, Stepped, Patient Preference–Based Treatment for Patients With Post–Acute Coronary Syndrome Depression: CODIACS Vanguard Randomized Controlled Trial." The other contributors are: J. Thomas Bigger, Matthew M. Burg, Joan Duer-Hefele, Vivian Medina, Jonathan D. Newman, Gabrielle A. Osorio, Faith Parsons, Jonathan A Shaffer, Peter A. Shapiro, William Whang, and Siqin Ye (CUMC); Robert M. Carney and Kenneth E. Freedland (Washington University); William F. Chaplin (St. John's University); Susan Czajkowski (NHLBI); Ellen Dornelas (Hartford Hospital, Yale University); Nancy Frasure-Smith (McGill University and New York University); Donald C. Haas (Penn Cardiac Care); Allan S. Jaffe (Mayo Clinic); Joseph A. Ladapo (New York University); Francois Lespérance (University of Montreal); Joseph E. Schwartz (CUMC and Stony Brook); David S. Sheps (University of Florida); and Viola Vaccarino (Emory).

The authors declare no financial or other conflicts of interest.

This work was supported by grant 5RC2HL101663, HL-088117, HL-084034 from the National Institutes of Health. This research was also supported by the Irving Institute for Clinical and Translational Research at CUMC, which is supported by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, through grant UL1 TR000040.

The Center for Behavioral Cardiovascular Health at Columbia University Medical Center is an interdisciplinary team of more than 40 scientists dedicated to understanding how and why behaviors, psychological factors, and societal forces influence hypertension and cardiovascular disease. The center conducts basic, translational, and clinical research and provides educational opportunities for health care professionals interested in this area.

Columbia University Medical Center provides international leadership in basic, pre-clinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center is home to the largest medical research enterprise in New York City and state and one of the largest faculty medical practices in the Northeast. For more information, visit cumc.columbia.edu or columbiadoctors.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Exploring the link between traumatic brain injury and people who are homeless

2013-03-21
TORONTO, March 21, 2013—Homeless people and their health care providers need to know more about traumatic brain injuries to help prevent and treat such injuries, a new study has found. Homeless people have a disproportionately higher risk for TBI compared to the general population, yet little is known about the severity of those injuries, who exactly is suffering from them and what the long-term consequences are. "A better understanding of TBI, its presentation and characteristics in the homeless is vital in order to enable appropriate interventions, treatments, and ...

Dysfunction in cerebellar Calcium channel causes motor disorders and epilepsy

2013-03-21
A dysfunction of a certain Calcium channel, the so called P/Q-type channel, in neurons of the cerebellum is sufficient to cause different motor diseases as well as a special type of epilepsy. This is reported by the research team of Dr. Melanie Mark and Prof. Dr. Stefan Herlitze from the Ruhr-Universität Bochum. They investigated mice that lacked the ion channel of the P/Q-type in the modulatory input neurons of the cerebellum. "We expect that our results will contribute to the development of treatments for in particular children and young adults suffering from absence ...

Misregulated genes may have big autism role

Misregulated genes may have big autism role
2013-03-21
PROVIDENCE, R.I. [Brown University] — A new study finds that two genes individually associated with rare autism-related disorders are also jointly linked to more general forms of autism. The finding suggests a new genetic pathway to investigate in general autism research. The genes encode the proteins NHE6 and NHE9, which are responsible for biochemical exchanges in the endosomes of cells. Mutations in the NHE6 gene are a direct cause of Christianson Syndrome, while mutations in the NHE9 gene lead to a severe form of autism with epilepsy. In the new study, a statistical ...

Planck's 'child' universe

Plancks child universe
2013-03-21
"We are very excited, we are finally seeing the concrete results of so many years of hard work". This is how the scientists of the Planck project have commented the first data resulting from the observations carried out by Planck. The mission of the ESA satellite is to observe the past of our Universe, going back in time and reaching the very first instant right after the Big Bang. The image that the Planck scientists convey today is that of a 'child' Universe, dating back to about 380,000 years after the Big Bang, when its temperature was similar to that of the most external ...

Genetic analysis calls for the protection of 2 highly endangered Portuguese fish species

Genetic analysis calls for the protection of 2 highly endangered Portuguese fish species
2013-03-21
The two endangered fish species, Squalius aradensis and S. torgalensis, most generally belong to the Cyprinidae, or the carp family. This is the largest fish, and vertebrate family, formed of freshwater fish with a diversity of more than 2,400 species. The family also has an important economic value as a food source. More specifically, the two species studied are members of the subfamily Leuciscinae, formed of small freshwater fish commonly known as minnows. A new genetic study of the two endangered fish was recently published in the open access journal Comparative Cytogenetics. S. ...

Genetics, age and ethnicity are risk factors in PCa, say experts

2013-03-21
"Are there genetic risk factors for PCa? Yes, and BRCA2 and HOXB13 are useful for predicting high-risk disease," said Jack Cuzick (GB) president of the International Society for Cancer Prevention (ISCaP), referring to the two genes implicated in high-risk prostate disease. Cuzick gave a report on the Consensus Statement for Prostate Cancer Prevention at the closing plenary session of the 28 Annual EAU Congress held in Milan, Italy from March 15 to 19. "The goal should be to integrate with other protein markers in order to develop risk-adapted screening algorithms," he ...

Novel insights into the evolution of protein networks

Novel insights into the evolution of protein networks
2013-03-21
This press release is available in German. System-wide networks of proteins are indispensable for organisms. Function and evolution of these networks are among the most fascinating research questions in biology. Bioinformatician Thomas Rattei, University of Vienna, and physicist Hernan Makse, City University New York (CUNY), have reconstructed ancestral protein networks. The results are of high interest not only for evolutionary research but also for the interpretation of genome sequence data. Recently, the researchers published their paper in the renowned journal PLOS ...

Planck challenges our understanding of the Universe

2013-03-21
Planck refines our knowledge of the Universe's composition and evolution New maps provide excellent evidence for our standard model of cosmology Planck dates Universe at 13.82 billion years old Anomalies suggest that Universe may be different on scales larger than those we can directly observe Most accurate values yet for the ingredients of the Universe, with normal matter contributing just 4.9% of the mass/energy density of the Universe and dark matter making up 26.8% - nearly a fifth more than the previous estimate. Europe's Planck satellite - a flagship mission ...

What you eat before surgery may affect your recovery

What you eat before surgery may affect your recovery
2013-03-21
BOSTON, MA—According to a new study, the last few meals before surgery might make a difference in recovery after surgery. Fat tissue is one of the most dominant components that make up the body, and fat tissue is always traumatized during major surgery. Researchers at Brigham and Women's Hospital (BWH) found that this direct trauma greatly impacts the chemical balance of fat tissue—chemicals that are known to communicate with nearby and distant organs. In the study, mice that consumed a typical Western, high-fat diet showed an exaggerated imbalanced response. Importantly, ...

Researchers tackle physician challenge of correctly ordering laboratory tests

2013-03-21
(Boston) – A new study involving researchers from the Boston University School of Medicine (BUSM) has identified barriers that clinicians face in correctly ordering appropriate laboratory tests and highlights some solutions that may simplify this process and improve patient outcomes. The study, published in the March 2013 issue of the Journal of General Internal Medicine, was led by Elissa Passiment, EdM, of the American Society for Clinical Laboratory Science and James L. Meisel, MD, associate professor of medicine at BUSM. Passiment, Meisel and colleagues identified ...

LAST 30 PRESS RELEASES:

A new way to produce ammonia more efficiently

Kennesaw State secures grant to build community of AI educators

Impact of decline in rescue breathing on child survival in Japan

High-status producers have the support to radically shift their artists’ image, while mid-status producers follow trends

High-performance electrode material that withstands seawater!

Targeted delivery of microRNA sponge short-hairpin RNA via VIR-inspired biotechnical vector: Enhancing cancer therapy

When politics drives entrepreneurial innovation

FAU researchers show adopting healthy habits can improve cognitive decline

Outstanding postdoctoral researchers honored with 2025 Blavatnik Regional Awards for Young Scientists

Fly through Gaia’s 3D map of stellar nurseries

Precision targeting of the centromedian nucleus in drug-resistant epilepsy highlighted in brain network disorders

Better understanding of bitter taste receptors: An AlphaFold3-based structure study

Artificial intelligence spots hidden signs of depression in students’ facial expressions

UT San Antonio astronomy professor awarded for advancements in planetary science

‘Internal alarm system’ harnesses immune system against cancer

Stem cell transplant for stroke leads to brain cell growth and functional recovery in mice

Cleveland Clinic study shows greater long-term benefits of bariatric surgery compared to GLP-1 medicines

Revised diagnostic criteria for vascular cognitive impairment and dementia—The VasCog-2-WSO criteria

The ATREIDES program in search of lost exo-Neptunes

Ancient crop discovered in the Canary Islands thanks to archaeological DNA

Placental research may transform our understanding of autism and human brain evolution

Mapping the Universe, faster and with the same accuracy

Study isolates population aging as primary driver of musculoskeletal disorders

Designing a sulfur vacancy redox disruptor for photothermoelectric and cascade‑catalytic‑driven cuproptosis–ferroptosis–apoptosis therapy

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

[Press-News.org] Can we treat a 'new' coronary heart disease risk factor?
Treating depression in those with coronary heart disease: CODIACS Vanguard Randomized Controlled Trial